Literature DB >> 26461248

Alexithymia predicts arousal-based processing deficits and discordance between emotion response systems during emotional imagery.

Catherine E Peasley-Miklus1, Georgia Panayiotou2, Scott R Vrana3.   

Abstract

Alexithymia is believed to involve deficits in emotion processing and imagery ability. Previous findings suggest that it is especially related to deficits in processing the arousal dimension of emotion, and that discordance may exist between self-report and physiological responses to emotional stimuli in alexithymia. The current study used a well-established emotional imagery paradigm to examine emotion processing deficits and discordance in participants (N = 86) selected based on their extreme scores on the Toronto Alexithymia Scale-20. Physiological (skin conductance, heart rate, and corrugator and zygomaticus electromyographic responses) and self-report (valence, arousal ratings) responses were monitored during imagery of anger, fear, joy, and neutral scenes and emotionally neutral high arousal (action) scenes. Results from regression analyses indicated that alexithymia was largely unrelated to responses on valence-based measures (facial electromyography, valence ratings), but that it was related to arousal-based measures. Specifically, alexithymia was related to higher heart rate during neutral and lower heart rate during fear imagery. Alexithymia did not predict differential responses to action versus neutral imagery, suggesting specificity of deficits to emotional contexts. Evidence for discordance between physiological responses and self-report in alexithymia was obtained from within-person analyses using multilevel modeling. Results are consistent with the idea that alexithymic deficits are specific to processing emotional arousal, and suggest difficulties with parasympathetic control and emotion regulation. Alexithymia is also associated with discordance between self-reported emotional experience and physiological response to emotion, consistent with prior evidence. (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 26461248     DOI: 10.1037/emo0000086

Source DB:  PubMed          Journal:  Emotion        ISSN: 1528-3542


  8 in total

1.  Affect labeling and other aspects of emotional experiences in relation to alexithymia following standardized emotion inductions.

Authors:  Rachel V Aaron; Matthew A Snodgress; Scott D Blain; Sohee Park
Journal:  Psychiatry Res       Date:  2018-02-05       Impact factor: 3.222

Review 2.  The process of emotion identification: Considerations for psychiatric disorders.

Authors:  Kristen P Morie; Michael J Crowley; Linda C Mayes; Marc N Potenza
Journal:  J Psychiatr Res       Date:  2022-02-02       Impact factor: 4.791

3.  Invisible side of emotions: somato-motor responses to affective facial displays in alexithymia.

Authors:  Cristina Scarpazza; Elisabetta Làdavas; Luigi Cattaneo
Journal:  Exp Brain Res       Date:  2017-11-17       Impact factor: 1.972

4.  Assessing the coherence of narratives of traumatic events with latent semantic analysis.

Authors:  Scott R Vrana; Rose S Bono; Andrea Konig; Gabriella C Scalzo
Journal:  Psychol Trauma       Date:  2018-10-22

5.  Association Between Alexithymia and Functional Gastrointestinal Disorders.

Authors:  Michiko Kano; Yuka Endo; Shin Fukudo
Journal:  Front Psychol       Date:  2018-04-25

6.  Emotional Arousal During Social Stress in Young Adults With Autism: Insights From Heart Rate, Heart Rate Variability and Self-Report.

Authors:  Renee R Dijkhuis; Tim Ziermans; Sophie van Rijn; Wouter Staal; Hanna Swaab
Journal:  J Autism Dev Disord       Date:  2019-06

7.  Do alexithymia and negative affect predict poor sleep quality? The moderating role of interoceptive sensibility.

Authors:  Yun-Hsin Huang; Chien-Ming Yang; Ya-Chuan Huang; Yu-Ting Huang; Nai-Shing Yen
Journal:  PLoS One       Date:  2022-10-03       Impact factor: 3.752

8.  Alexithymia and emotional reactions to odors.

Authors:  Cinzia Cecchetto; Raffaella Ida Rumiati; Marilena Aiello
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.